Active |
|
|
Principal
Investigator |
Co-Investigator
|
|
Mansoor M Ahmed
|
|
TGF-b1 signaling and radiation response in
pancreas cancer. RO-1
grant from National Cancer Institute, NIH ? Direct and Indirect $
698,008
(April 2002 ? March 2005).
|
Mansoor
M Ahmed |
|
TGF-b signaling
and radiation response in lung
carcinoma. Kentucky Lung Cancer Research
Board. Direct and Indirect $250,000
(October 2001 to September 2004). |
Susanne
M. Arnold, |
Mansoor M Ahmed
|
Low-dose
fractionated
radiation plus Docetaxel and
Cisplatin as induction therapy for stage II and IIIA non-small cell
lung
cancer. Kentucky Lung Cancer
Research Board. Direct and Indirect
$200,000 (March 2003 to Febraury 2005). |
Damodaran
Chendil |
Mansoor M Ahmed
|
Inhibition of
radiation-induced pro-survival proteins
by Curcumin, a natural dietary compound. Career Award funded by US Army
Medical
Research and Materiel Command-PCRP - Direct: $81,500/year (April 2003
to March 2005). |
Paul M.
Spring, |
Mansoor M Ahmed
|
Multi-drug
resistance and low-dose fractionated
radiation. Aventis Pharmaceuticals, NJ. Direct and Indirect $40,353
(September
2001 to August 2002). |
Mariana Saltanov |
Mansoor
M Ahmed (Mentor) |
EGR-1 functional
activation, signaling and radiation
response in prostate cancer. US Army Medical Research and Materiel
Command-PCRP
/ Post-doctoral Award. Direct and Indirect $ 97,672 for 2 year. |
Seema
Gupta |
Mansoor M Ahmed (Mentor) |
Radiosensitizing
effects
of novel HDAC inhibitors in
prostate cancer. US Army Medical Research and Materiel Command-PCRP /
Post-doctoral Award. Direct and Indirect $ 98,000 for 2 year |
Pending |
|
|
Mansoor M Ahmed |
|
Biology of
spatially
fractionated
radiation. RO-1 grant application. National Cancer Institute, NIH ? Direct
$1,250,000. (First
round Percentile 47% and score 264).
|
Mansoor M Ahmed |
|
Hyper-radiation
sensitivity and chemo-potentiation in
treatment of solid tumors. RO-1 grant application.
National Cancer Institute, NIH ? Direct
$1,250,000. |
Paul
M.
Spring, |
Mansoor
M Ahmed |
Novel
strategy to
reverse chemo-resistance in
anaplastic cancer. VA-Research Career Development Award.
|
|
|
|
Awarded
|
|
|
Mansoor M Ahmed
|
|
EGR-1 and
apoptosis in
prostate cancer. RO-1 grant from National
Cancer Institute,
NIH ? Direct and Indirect $742,837 (July 1999 ? December 2003). |
Mansoor M Ahmed
|
|
Defining the
genetic
basis of chemosensitization of
Taxotere with low dose fractionated radiation. Aventis Pharmaceuticals,
NJ.
Direct and Indirect $40,353 |
Mansoor M Ahmed |
|
Role of Early
Growth
Response-1 (Egr-1) gene in radiation-induced apoptosis
of prostate cancer
cells. Career Award funded by US Army
Medical Research and Materiel Command - Direct: $63,902/year (July 1998
to
April 2001). |
Mansoor
M Ahmed |
|
Evaluation of Egr-1
overexpression and mutation in
prostate adenocarcinomas. Funded by
Translation Research Program of Radiation Therapy Oncology Group (RTOG)
-
$5,000/year (July 1998 to June 2001).
|
Mansoor M Ahmed
|
|
Evaluation of
overexpression of growth-inhibitory and
cell death regulatory genes in pancreatic adenocarcinomas : A
correlative study
using specimens from RTOG protocol number 97-04. Funded
by Markey Cancer Center Trust Fund -
$7,500/year (March 1999 to Feb 2000). |
Mansoor M Ahmed
|
|
EGR-1 and
apoptosis in
prostate cancer. Bridge funding by
Charlotte Geyer Foundation,
New York - $99,998 (July 1998 to June 1999). |
Mohammed
Mohiuddin,
|
Mansoor M Ahmed |
A phase I
dose-escalation
trial of combined therapy
with L-778,123 and radiotherapy in patients with cancer Funded by Merck &
Co - $13600/patient (March 1999 to Febraury 2000).
|
Nader
N Hanna |
Mansoor
M Ahmed |
Radiogene
therapy in
solid tumors. Funded
by American Cancer Society Institutional Research Grant (Markey Cancer
Center)
- $15,000/year (July 1998 ? June 1999). |
James W. Freeman,
|
Mansoor
M Ahmed
|
TGF-b
alterations in
pancreatic cancer. Supported University of Kentucky Research
Foundation (Equipment grant - 1996 $15,000). |
Joseph Valentino
|
Mansoor M Ahmed
|
Genotype and
phenotype
analysis
in head and neck tumors using fluorescent in-situ hybridization Supported
by University of Kentucky Medical Research Foundation (Equipment grant
-1994 $29,000).
|
Mohammed
Mohiuddin |
Mansoor
M Ahmed |
Detection of
circulating
minimal
malignant clone Supported by University of Kentucky Medical
Research Foundation ($15,000): 1994-95.
|